UBS AM’s Repare Therapeutics RPTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q1 | – | Sell |
-144,424
| Closed | -$2.12M | – | 2708 |
|
2022
Q4 | $2.12M | Buy |
144,424
+22,080
| +18% | +$325K | ﹤0.01% | 1499 |
|
2022
Q3 | $1.48M | Sell |
122,344
-18,429
| -13% | -$224K | ﹤0.01% | 1751 |
|
2022
Q2 | $1.97M | Sell |
140,773
-5,217
| -4% | -$73K | ﹤0.01% | 1623 |
|
2022
Q1 | $2.08M | Sell |
145,990
-11,614
| -7% | -$165K | ﹤0.01% | 1777 |
|
2021
Q4 | $3.32M | Sell |
157,604
-2,895
| -2% | -$61.1K | ﹤0.01% | 1609 |
|
2021
Q3 | $4.21M | Sell |
160,499
-5,520
| -3% | -$145K | ﹤0.01% | 1437 |
|
2021
Q2 | $5.18M | Sell |
166,019
-15,672
| -9% | -$489K | ﹤0.01% | 1353 |
|
2021
Q1 | $5.58M | Buy |
181,691
+4,948
| +3% | +$152K | ﹤0.01% | 1289 |
|
2020
Q4 | $6.06M | Sell |
176,743
-10,526
| -6% | -$361K | ﹤0.01% | 1216 |
|
2020
Q3 | $5.76M | Buy |
187,269
+2,535
| +1% | +$78K | ﹤0.01% | 1101 |
|
2020
Q2 | $5.73M | Buy |
+184,734
| New | +$5.73M | ﹤0.01% | 1066 |
|